Ethyl 6-(bromomethyl)-2-oxo-4-(thiophen-2-yl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate

Catalog No. :
ACWWDV473
CAS No. :
15139-62-5
Molecular Formula :
C12H13BrN2O3S
Molecular Weight :
345.22

IUPAC Name:ethyl 6-(bromomethyl)-2-oxo-4-(thiophen-2-yl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate

Ethyl 6-(bromomethyl)-2-oxo-4-(thiophen-2-yl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 6-(bromomethyl)-2-oxo-4-(thiophen-2-yl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate
IUPAC Nameethyl 6-(bromomethyl)-2-oxo-4-(thiophen-2-yl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate
MDL No.MFCD04623491
Molecular FormulaC12H13BrN2O3S
Molecular Weight345.22
SMILESO=C(C1=C(CBr)NC(NC1C2=CC=CS2)=O)OCC
InChI KeyIKBCZZXKROFYMW-UHFFFAOYSA-N
SynonymETHYL 6-(BROMOMETHYL)-2-OXO-4-THIEN-2-YL-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOXYLATE;6-bromomethyl-2-oxo-4-thiophen-2-yl-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid ethyl ester;5-Pyrimidinecarboxylic acid, 6-(bromomethyl)-1,2,3,4-tetrahydro-2-oxo-4-(2-thienyl)-, ethyl ester;Ethyl 6-(bromomethyl)-2-oxo-4-(thiophen-2-yl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate
CAS No.15139-62-5

Synthetic Route by SureRoute

1. ACWWDV473 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWWDV473 route product structure diagram
    ACWWDV47315139-62-5
Inquiry

2. ACWWDV473 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWWDV473 route product structure diagram
    ACWWDV47315139-62-5
Inquiry

Comments (0)